Dynacor Group Inc. has received approval from the Toronto Stock Exchange to renew its normal course issuer bid, allowing it to repurchase up to 3,845,230 common shares, about 10% of its public float. This buyback program, running from May 6, 2026, to May 5, 2027, aims to enhance shareholder value using existing cash reserves. The company has repurchased 508,500 shares under the previous program and plans to continue evaluating opportunities to return cash to shareholders. Dynacor also expects to report its first-quarter 2026 financial results around May 14, 2026.
Mirum Pharmaceuticals is rapidly growing as a leader in liver disease treatments, raising its 2026 global sales forecast to $660–$680 million due to strong performance of its drug LIVMARLI. Although recent acquisitions have delayed the company’s cash...
Nigel Farage has been reported to the UK Parliament’s standards watchdog over allegations that he lobbied the Bank of England on cryptocurrency policy in ways that could benefit Christopher Harborne, a major investor in stablecoin issuer Tether who h...
UnitedHealth Group remains a strong long-term investment despite recent operational challenges and price increases. Management targets 13–16% bottom-line growth driven by margin recovery, AI investments, and share buybacks. Current valuations suggest...
MemeCore surged over 42% after the Foundation announced a $10 million strategic buyback program to address a recent 85% price crash. Despite the initial rally, the altcoin fell more than 5% within 24 hours, reflecting ongoing market uncertainty. For ...
Ouster, Inc. raised $200 million, increasing its pro forma cash to about $375 million to support large-scale customer growth and inventory for Physical AI applications. The company has customers planning rapid expansion, with unit growth targets rang...
